5-(FORMYLAMINO)-1-(2,3,5-TRI-O-FORMYL-.BETA.-D-RIBOFURANOSYL)-1H-IMIDAZOLE-4-CARBOTHIOAMIDE
UNII TW6NAG8LRS
Substance Identification & Data
This profile provides standardized clinical and technical data for 5-(formylamino)-1-(2,3,5-tri-o-formyl-.beta.-d-ribofuranosyl)-1h-imidazole-4-carbothioamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) TW6NAG8LRS.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 27115-65-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C13H14N4O8S DQTIIYOPXVPKDM-QYVSTXNMSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 5-(formylamino)-1-(2,3,5-tri-o-formyl-.beta.-d-ribofuranosyl)-1h-imidazole-4-carbothioamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.